Cargando…
Pancreatic-specific autoantibodies to glycoprotein 2 mirror disease location and behaviour in younger patients with Crohn’s disease
BACKGROUND: Glycoprotein 2 (GP2) was discovered as the major autoantigen of Crohn’s disease (CD)-specific pancreatic autoantibodies (PAB). We investigated anti-GP2 IgA and IgG antibodies as novel serological parameters in CD and assessed their association with distinct disease phenotypes. METHODS: A...
Autores principales: | Bogdanos, Dimitrios P, Roggenbuck, Dirk, Reinhold, Dirk, Wex, Thomas, Pavlidis, Polychronis, von Arnim, Ulrike, Malfertheiner, Peter, Forbes, Alastair, Conrad, Karsten, Laass, Martin W |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3449192/ https://www.ncbi.nlm.nih.gov/pubmed/22866900 http://dx.doi.org/10.1186/1471-230X-12-102 |
Ejemplares similares
-
Ileal Inflammation May Trigger the Development of GP2-Specific Pancreatic Autoantibodies in Patients with Crohn's Disease
por: Pavlidis, Polychronis, et al.
Publicado: (2012) -
Loss and Gain of Tolerance to Pancreatic Glycoprotein 2 in Celiac Disease
por: Laass, Martin W., et al.
Publicado: (2015) -
Identification of Chitinase-3-Like Protein 1 as a Novel Neutrophil Antigenic Target in Crohn’s Disease
por: Deutschmann, Claudia, et al.
Publicado: (2019) -
Autoimmune Peripheral Neuropathies and Contribution of Antiganglioside/Sulphatide Autoantibody Testing
por: Roggenbuck, Dirk, et al.
Publicado: (2020) -
Next-Generation Autoantibody Testing by Combination of Screening and Confirmation—the CytoBead® Technology
por: Sowa, Mandy, et al.
Publicado: (2016)